Wyeth Drugs and company information by Ray Sahelian, M.D. Medications sold
Feb 12 2014

Wyeth drug company focuses on small molecules, vaccines and biotechnology. Wyeth is exploring more than 60 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer’s disease and schizophrenia. Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009.

Advil Brands for aches and pains
Alavert for allergies. Loratadine, a second generation H1-antagonist, is prescribed as a treatment for patients with allergic rhinitis.
Alesse (0.1 mg levonorgestrel/0.02 mg ethinyl estradiol tablets) for  women's health
Alatace (ramipril) for cardiovascular
Anbesol for oral Health
Antivenin (Crotalidae) Polyvalent (equine origin) for infectious disease
Antivenin (Micrurus Fulvius) (Equine Origin) North American Coral Snake
BeneFIX Coagulation Factor IX (Recombinant) in hematology
Caltrate for osteoporosis
Cefa-Lak - Cefa-Dri for mastitis (Lactating cows)
Centrum Brands Nutrition & Vitamins
ChapStick Oral Health
Cordarone (amiodarone HCl) Tablets Cardiovascular
Cydectin Bovine endoparasites Bovine ectoparasites
Dimetapp Allergies Cold and Flu
Duramune Adult Canine distemper Canine adenovirus Canine parvovirus
Duramune Max Canine distemper Canine adenovirus Canine parvovirus Canine Leptospirosis Canine parainfluenza
Effexor (venlafaxine HCl) Tablets Neuroscience
Prevnar, made by the drug company Wyeth, has been used in the United States since 2000.
Pristiq - In February 2008, Wyeth received approval by the FDA for a new antidepressant called Pristiq. Wyeth needs an antidepressant that will replace the revenue expected to be reduced  to generic competitors of Effexor XR, whose patent protection expires in 2010. Pristiq is chemically similar to Effexor.

Wyeth and Prempro lawsuit update
2007 - A Philadelphia jury found that Wyeth drug company's hormone replacement therapy Prempro was a cause of a woman's breast cancer and awarded her and her husband damages of $3 million,. Wyeth said it disagrees with the verdict and plans to appeal.

2007 - A Nevada jury awarded $99 million in punitive damages to three women who blamed their breast cancer on Wyeth hormone replacement drugs. Wyeth will appeal. It faces more than 5,000 lawsuits from those who believe they were harmed by hormone replacement treatments prescribed to women to ease symptoms of menopause. The drugs, Premarin and Prempro, remain available on the U.S. market. The Reno case is the seventh to reach a verdict since trials began in the hormone therapy litigation last year. Wyeth has claimed victory in the six previous cases, although one verdict against Wyeth was overturned and judgment entered in favor of Wyeth and two other plaintiffs' verdicts were thrown out and new trials ordered, the company said.